imiquimod has been researched along with axitinib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dainichi, T; Hirakawa, S; Honda, T; Kabashima, K; Kitoh, A; Miyachi, Y; Nakajima, S; Nakashima, C; Nonomura, Y; Otsuka, A; Wong, LS; Yamamoto, Y | 1 |
| Jiang, X; Li, X; Liu, L; Yang, L; Zhao, Q | 1 |
1 review(s) available for imiquimod and axitinib
| Article | Year |
|---|---|
Pathogenesis of Port-Wine Stains: Directions for Future Therapies.
Topics: Angiopoietin-2; Axitinib; Ephrin-B2; Humans; Imiquimod; Phosphatidylinositol 3-Kinases; Photosensitizing Agents; Port-Wine Stain; Proto-Oncogene Proteins c-akt; Receptor, EphA1; Ribosomal Protein S6 Kinases, 70-kDa; Sirolimus; Treatment Outcome; Vascular Endothelial Growth Factor Receptor-2 | 2022 |
1 other study(ies) available for imiquimod and axitinib
| Article | Year |
|---|---|
Vascular endothelial growth factor partially induces pruritus via epidermal hyperinnervation in imiquimod-induced psoriasiform dermatitis in mice.
Topics: Aminoquinolines; Animals; Axitinib; Dermatitis, Atopic; Disease Models, Animal; Epidermis; Humans; Imidazoles; Imiquimod; Indazoles; Mice; Pruritus; Psoriasis; Receptors, Vascular Endothelial Growth Factor; Vascular Endothelial Growth Factor A | 2016 |